Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Viral hybrid-vectors for delivery of autonomous replicons.

Zhang W, Hagedorn C, Schulz E, Lipps HJ, Ehrhardt A.

Curr Gene Ther. 2014 Feb;14(1):10-23. Review.

PMID:
24365145
2.

Sleeping Beauty-baculovirus hybrid vectors for long-term gene expression in the eye.

Turunen TA, Laakkonen JP, Alasaarela L, Airenne KJ, Ylä-Herttuala S.

J Gene Med. 2014 Jan-Feb;16(1-2):40-53. doi: 10.1002/jgm.2756.

PMID:
24464652
3.

Stable transduction of actively dividing cells via a novel adenoviral/episomal vector.

Leblois H, Roche C, Di Falco N, Orsini C, Yeh P, Perricaudet M.

Mol Ther. 2000 Apr;1(4):314-22.

4.

Herpes simplex virus type 1 amplicons and their hybrid virus partners, EBV, AAV, and retrovirus.

Oehmig A, Fraefel C, Breakefield XO, Ackermann M.

Curr Gene Ther. 2004 Dec;4(4):385-408. Review.

PMID:
15578989
5.

Integrase-defective lentiviral vectors--a stage for nonviral integration machineries.

Staunstrup NH, Mikkelsen JG.

Curr Gene Ther. 2011 Oct;11(5):350-62. Review.

PMID:
21745178
6.

Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.

Philippe S, Sarkis C, Barkats M, Mammeri H, Ladroue C, Petit C, Mallet J, Serguera C.

Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17684-9. Epub 2006 Nov 9.

7.

Prolonged transgene expression in glomeruli using an EBV replicon vector system combined with HVJ liposomes.

Tsujie M, Isaka Y, Nakamura H, Kaneda Y, Imai E, Hori M.

Kidney Int. 2001 Apr;59(4):1390-6.

8.

Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides.

Weber C, Armbruster N, Scheller C, Kreppel F, Kochanek S, Rethwilm A, Steinert AF.

J Gene Med. 2013 Mar-Apr;15(3-4):155-67. doi: 10.1002/jgm.2705.

PMID:
23554302
9.

Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells.

Dorigo O, Gil JS, Gallaher SD, Tan BT, Castro MG, Lowenstein PR, Calos MP, Berk AJ.

J Virol. 2004 Jun;78(12):6556-66.

10.
11.

Development of herpesvirus-based episomally maintained gene delivery vectors.

Calderwood MA, White RE, Whitehouse A.

Expert Opin Biol Ther. 2004 Apr;4(4):493-505. Review.

PMID:
15102599
12.

EBV replicon vector system enhances transgene expression in vivo: applications to cancer gene therapy.

Otomo T, Yamamoto S, Morishita R, Kaneda Y.

J Gene Med. 2001 Jul-Aug;3(4):345-52.

PMID:
11529664
13.

Replicon-based vectors of positive strand RNA viruses.

Khromykh AA.

Curr Opin Mol Ther. 2000 Oct;2(5):555-69. Review.

PMID:
11249758
14.

Viral vectors for gene transfer: a review of their use in the treatment of human diseases.

Walther W, Stein U.

Drugs. 2000 Aug;60(2):249-71. Review.

PMID:
10983732
15.

Self-focusing therapeutic gene delivery with intelligent gene vector swarms: intra-swarm signalling through receptor transgene expression in targeted cells.

Tolmachov OE.

Artif Intell Med. 2015 Jan;63(1):1-6. doi: 10.1016/j.artmed.2014.11.001. Epub 2014 Dec 17.

PMID:
25547266
16.

Generation of a tumor- and tissue-specific episomal non-viral vector system.

Haase R, Magnusson T, Su B, Kopp F, Wagner E, Lipps H, Baiker A, Ogris M.

BMC Biotechnol. 2013 Jun 4;13:49. doi: 10.1186/1472-6750-13-49.

17.

Episomal vectors for gene therapy.

Ehrhardt A, Haase R, Schepers A, Deutsch MJ, Lipps HJ, Baiker A.

Curr Gene Ther. 2008 Jun;8(3):147-61. Review.

PMID:
18537590
18.

Replicon vectors derived from Sindbis virus and Semliki forest virus that establish persistent replication in host cells.

Perri S, Driver DA, Gardner JP, Sherrill S, Belli BA, Dubensky TW Jr, Polo JM.

J Virol. 2000 Oct;74(20):9802-7.

19.

Non-viral amplification systems for gene transfer: vectors based on alphaviruses.

Smerdou C, Liljeström P.

Curr Opin Mol Ther. 1999 Apr;1(2):244-51. Review.

PMID:
11715947
20.

Viral gene therapy.

Mancheño-Corvo P, Martín-Duque P.

Clin Transl Oncol. 2006 Dec;8(12):858-67. Review.

PMID:
17169759

Supplemental Content

Support Center